Transforming growth factor-b (TGF-b) signaling has been linked with tubular epithelial to mesenchymal cell transition. In this study, we examined the role of Arkadia, an E3 ubiquitin ligase that is critically required for TGF-b signaling during epithelial to mesenchymal cell transition. We found that when normal human renal tubular epithelial cells in culture were stimulated with TGF-b1, which increased their levels of Arkadia, Smurf2, TGF-b type I receptor (TbRI), and Smad7 mRNA, but had low levels of Smad7 protein. When these cells were preincubated with Arkadia siRNA (small interfering RNA) and lactacystin (an inhibitor of proteasomal degradation), the TGF-b 1 induced expression of Smad7, a-smooth muscle actin, and E-cadherin was partly reversed, but the expression of TbRI protein and Smad7 mRNA was not affected. In contrast, Smurf2 siRNA had no influence on the expression of these targets. Our studies suggest that Arkadia stimulates renal tubular epithelial to mesenchymal cell transition through degradation of Smad7. Tubulointerstitial fibrosis is a final common feature of endstage renal damage in various types of kidney diseases, 1 and renal tubular epithelial to mesenchymal cell transition (EMT) plays a key role in the process.
Tubulointerstitial fibrosis is a final common feature of endstage renal damage in various types of kidney diseases, 1 and renal tubular epithelial to mesenchymal cell transition (EMT) plays a key role in the process. 2 Tubular EMT is a process in which renal tubular epithelial cells lose their epithelial phenotype and acquire new characteristic features of mesenchyme, which includes disruption of polarized tubular epithelial cell morphology, de novo a-smooth muscle actin (a-SMA) expression and actin reorganization, loss of cell-cell adhesions through downregulation of E-cadherin, destruction of basement membrane, and increased cell migration and invasion. 2, 3 TGF-b 1 is a multifunctional cytokine that affects a variety of biological processes, including extracellular matrix accumulation, differentiation, cell cycle, and apoptosis. 4 Extensive clinical and experimental studies have suggested that TGF-b 1 is the most potent inducer that is capable of initiating and completing the EMT course. 2 Previous studies reported that TGF-b 1 -induced Smad2 phosphorylation results in the transformation of tubular epithelial cell into a myofibroblast phenotype with the loss of E-cadherin and de novo expression of a-SMA, collagens, I, III and IV in a normal rat tubular epithelial cell. 5 Moreover, overexpression of inhibitory Smad7 was found to abolish Smad2 phosphorylation and tubular cell phenotypic conversion. 5 These results suggest that TGF-b 1 -induced EMT is primarily dependent on the positive or negative regulation of Smad signaling. 6 Smad proteins are critical intracellular mediators in the TGF-b signaling pathway. The process of TGF-b/Smad signaling pathway activation is as follows: upon TGF-b stimulation, the activated TbRI associates transiently with R-Smads (Smad2 and Smad3) and also phosphorylates them. Then the phosphorylated R-Smads dissociate from the receptor, bind to Smad4, and translocate into the nucleus, where such a complex controls the transcription of TGF-b responsive genes together with additional DNA-binding cofactors. In contrast with R-Smads, Smad7 prevents or attenuates TGF-b signaling through multiple mechanisms, including interaction with activated TbRI and prevention of R-Smad phosphorylation. 7, 8 Fukasawa et al. 9 demonstrated that significant immunostaining of Smad7 was noted in tubular epithelial cells in sham-operated kidneys; however, immunoreactivity for Smad7 was markedly decreased in unilateral ureteral obstruction (UUO) kidneys, and the finding was further confirmed by western blot. Moreover, the expression of Smad7 mRNA is gradually increased in obstructed kidneys compared with sham-operated kidneys. 9 In addition, Wang et al. 10 indicated that Smad7 protein was markedly decreased in normal mesangial cells stimulated with high glucose compared with the normal mesangial cells. Accumulative evidence indicates that Smad7 protein in some tissue and organ fibrosis is obviously lower than that of the normal control, 9, [11] [12] [13] [14] [15] and also demonstrates that upregulated Smad7 protein expression by transfection of the Smad7 gene in vivo and in vitro can reverse or block fibrogenesis. 12, 16 These studies suggested that Smad7 plays a key role in the regulation of Smad-mediated TGF-b signaling during progression of EMT and fibrosis in various diseases. Therefore, understanding the reasons for low levels of Smad7 in fibrotic diseases is of significance in the progression of treatment and prevention of fibrosis.
The levels of some cellular proteins are modulated dynamically by the ubiquitin-proteasome degradation pathway. 17, 18 Smad protein is also regulated by this degradation pathway. E3 ubiquitin ligases, such as Arkadia and Smurfs, are involved in the ubiquitin-dependent proteasomal degradation of Smad7.
19 Smad7 has been shown to function as an adapter protein that recruits ubiquitin ligases, termed Smurfs, to the TGF-b receptor complex to promote its degradation through proteasomal pathways. 20, 21 In contrast with Smurfs, Arkadia regulates the transcriptional activity of TGF-b only through degradation of Smad7 but not that of TGF-b receptors. 19 Owing to the discrepancy of Arkadia and Smurfs, they have distinct roles in amplification or inhibition of TGF-b signaling. In view of Arkadia being of relative specificity and uniqueness in degrading Smad7, the major focus of this study is to understand the role of Arkadia and Smad7 in the pathogenesis of tubular EMT.
RESULTS

Expression of a-SMA and E-cadherin in HKCs stimulated with TGF-b 1
Consistent with previous reports, 5 our results also demonstrated that the expression of a-SMA, a myofibroblast marker, is increased in a time-dependent manner in HKCs (human renal tubular epithelial cells) stimulated with TGF-b 1 compared with control HKCs, whereas the expression levels of E-cadherin, a molecule that plays a key role in maintaining the integrity of epithelial cells and is regarded as an epithelial marker, is decreased in HKCs stimulated with TGF-b 1 in a time-dependent manner compared with control HKCs (Figure 1 ).
Expression of Smad7 mRNA and protein in HKCs stimulated with TGF-b 1 The expression levels of Smad7 protein between control HKCs and HKCs stimulated with TGF-b 1 were detected by western blot. The results showed that the expression level of Smad7 protein was moderate and persistent in control HKCs and gradually, but significantly, decreased in a timedependent manner in HKCs stimulated with TGF-b 1 . To investigate whether the reduction of Smad7 protein was the result of downregulation of Smad7 mRNA, we analyzed the mRNA expression of Smad7 by real-time reverse transcription-PCR (real time RT-PCR). In contrast to the significant decrease of Smad7 protein, the Smad7 mRNA expression was increased in HKCs stimulated with TGF-b 1 compared with control HKCs. These results suggest that there could be some materials degrading Smad7 protein during the renal tubular EMT (Figure 2 ). The expression levels of Arkadia, Smurf2, and TbRI in control HKCs and HKCs stimulated with TGF-b 1 were detected by western blot. The results showed that Arkadia, Smurf2, and TbRI were expressed weakly in control HKCs; however, the expressions of Arkadia, Smurf2, and TbRI proteins were gradually increased in HKCs stimulated with TGF-b 1 ( Figure 3 ).
Arkadia can interact with Smad7 in HKCs
To investigate the respective interaction of Arkadia with Smad7 and TbRI in HKCs, cell lysates collected from control HKCs and HKCs stimulated with TGF-b 1 for 24 h were immunoprecipitated by using anti-Smad7 or anti-TbRI, followed by immunoblotting using the corresponding antibody. In HKCs stimulated with TGF-b 1 , the complex composed of Arkadia-Smad7 and that of Smurf2-Smad7 were all noted. In addition, the complex composed of Smurf2-TbRI was noted; however, no complex composed of Arkadia and TbRI was detected. The present findings indicated that Smad7 can interact with Arkadia or Smurf2, and TbRI could interact with Smurf2 but not with Arkadia in HKCs. Taken together with the previous results that TbRI expression level was increased in HKCs stimulated with TGF-b 1 , our findings suggest that the low expression of Smad7 could be mainly attributed to the high expression of Arkadia in HKCs stimulated with TGF-b 1 ( Figure 4 ). 
DISCUSSION
Accumulating evidence suggests that tubular EMT plays a pathogenic role in renal tubulointerstitial fibrosis, 2 and TGF-b /Smad signaling is a central pathway in regulating tubular EMT.
6 Smad7, an intracellular antagonist for TGF-b signaling, associates with the activated TGF-b receptor, which interferes with the activation of Smad2 and Smad3 by preventing their interaction with activated TGF-b receptors and consequent phosphorylation. 7, 8 Therefore, it is conceivable that the cellular level of Smad7 is a major determinant of TGF-b responses, which could regulate the intensity and duration of TGF-b signals. Recent studies have showed that the ubiquitin-proteasome pathway has an important influence on TGF-b signaling through regulating Smads degradation, including Smad7.
12 E3 ubiquitin ligases, such as Arkadia and Smurfs, play an important role in the process of degradation. Smad7 has been shown to function as an adapter protein that recruits Arkadia or links TGF-b receptor to Smurfs, resulting in Smad7 or Smad7-TGF-b receptor complex degradation through proteasomal pathways. [19] [20] [21] The relationship between Smurfs and Smad7 has been investigated in some diseased models, such as renal fibrosis and scleroderma. Asano et al. 22 reported that scleroderma fibroblasts exhibited increased Smad7 and TbRI levels compared with normal fibroblasts, but there was no significant difference in Smurfs levels between normal and scleroderma fibroblasts, and the transiently overexpressed Smurfs did not affect TbRI protein levels in scleroderma fibroblasts. These results suggested that Smurf2-Smad7-TbRI-mediated negative regulation of TGF-b signaling was impaired, which might contribute to maintaining the autocrine TGF-b loop in scleroderma; 22 otherwise, Smurf2 should lead to inhibition of TGF-b signaling through degradation of TbRI and Smad7. Fukasawa et al. reported low expression levels of Smad7 protein, but high levels of Smad7 mRNA, and both degradation and ubiquitination of Smad7 protein were markedly increased in UUO kidneys, in which both Smurf2 and Smurf1 expression were increased, and Smurf2 was more evident than Smurf1 in the process of Smad7 ubiquitination. The findings suggested that accelerated degradation of Smad7 by the ubiquitin-proteasome pathway, which could be mediated by Smurf proteins, contributed to the reduction of Smad7 in fibrotic UUO kidneys. 9 However, the study only demonstrated the effect of Smurfs on Smad7, but the expression of TbRI and the relationship between Smurfs and TbRI had not been investigated. Taken together, it seems that Smurfs have distinct roles in amplification or inhibition of TGF-b signaling in various disease processes.
In agreement with the study by Fukasawa, 9 we also demonstrated a significant increase of Smurf2 protein and Smad7 mRNA expression levels and a dramatic reduction of Smad7 protein in UUO kidneys, moreover, our results also indicated that the expression of Arkadia and TbRI proteins was increased in UUO kidneys. 23 These results seem to be contradictory to the notion that high expression levels of Smurf2 will result in the degradation of TGF-b receptor and Smad7.
In contrast with Smurfs, it is very important that Arkadia is not recruited to TGF-b receptors and does not induce their degradation. 19 In other words, Arkadia regulates the transcriptional activity of TGF-b signaling through degradation of Smad7 but not through that of TGF-b receptors. 19 In accordance with the in vivo studies. 9, 23 We demonstrated a significant increase of Smad7 mRNA expression levels and a reduction of Smad7 protein in HKCs treated with TGF-b 1 . In addition, our results also indicated that the expression of Arkadia, Smurf2, and TbRI proteins was increased in HKCs treated with TGF-b 1 . Moreover, immunoprecipitation analysis indicated that Smurf2 could interact with Smad7 and TbRI, and Arkadia only interacts with Samd7 but not with TbRI in HKCs. In view of the findings mentioned above, we speculated that the reduction of Smad7 is mainly mediated by Arkadia but not by Smurf2.
To test this presumption, we knocked down the expression of endogenous Arkadia and Smurf2 by using siRNA. The results indicate that Arkadia siRNA increase smad7 protein expression in the HKCs stimulated with TGF-b 1 , but Smurf2 siRNA dose not affect Smad7 protein expression. There was no significant difference in the expression of Smad7 mRNA and TbRI protein between the HKCs stimulated with TGF-b 1 and the HKCs stimulated with TGF-b 1 in the presence of Arkadia siRNA. The result suggested that Arkadia did not affect TbRI levels and also ruled out transcriptional suppression of the expression of Smad7 gene in HKCs. Similar to Arkadia siRNA, smad7 protein expression in the HKCs stimulated with TGF-b 1 was elevated by lactacystin. These results further confirmed that degradation of Smad7 by the ubiquition-proteasome pathway, which could be mainly attributed to Arkadia, contributes to the reduction of Smad7 protein in HKCs stimulated with TGF-b 1 .
Because the process of tubular EMT can be blocked by overexpression of Smad7, 5 and because of the tight association between Arkadia and Smad7, we further investigated the effect of Arkadia siRNA on tubular EMT induced by TGF-b 1 . In agreement with Li's study, 5 we also demonstrated that there was a significant increase of a-SMA expression and a loss of E-cadherin in HKCs stimulated with TGF-b 1 compared with the control HKCs in a time-dependent manner, which suggested that renal tubular cells lost their epithelial phenotype and acquired new characteristic features of mesenchyme. Subsequently, a-SMA expression was decreased and E-cadherin expression was increased in HKCs stimulated with TGF-b 1 in the presence of Arkadia siRNA compared with the HKCs stimulated with TGF-b1. These results suggest that Arkadia siRNA is able to relieve the degree of renal EMT through upregulated Smad7 expression; in other words, Arkadia could positively contribute to renal tubular EMT through degradation of Smad7.
MATERIALS AND METHODS Cell culture
Normal HKCs were grown in a 5% CO 2 atmosphere at 371C in 1640 medium containing 10% fetal bovine serum in six-well plastic plates. A recombinant human TGF-b 1 (R&D Systems) at concentrations of 5 ng ml À1 was added into the cell culture for periods of 0, 6, 12, 24, 48, and 72 h, then the expressions of a-SMA, E-cadherin, Smad7, Smad7 mRNA, Arkadia, Arkadia mRNA, Smurf2, and TbRI in HKCs stimulated with TGF-b 1 were detected by western blot and real-time RT-PCR. Subsequently, HKCs were stimulated with TGF-b 1 for 24 h in the presence or absence of the siRNA against Arkadia/Smurf2 (Genesil Biotechnology, Wuhan, China) (2 mg ml À1 , 24 h) and lactacystin (Sigma, St Louis, MO, USA) (10 mM, 3 h) for detecting the target material mentioned above.
RNA interference
The siRNA oligonucleotide sequences against Arkadia (GI: 37595552) and Smurf2 (GI: 56550041) were synthesized by Genesil Biotechnology. 
Western blot
Cells were lysed with Nonidet P-40 (NP-40) lysis buffer (20 mM TrisHCl pH 7.5, 150 mM NaCl, and 1% NP-40) in the presence of protease inhibitors at 41C. After incubation for 30 min, the lysates were centrifuged at 41C for 10 min at 10 000 g. The protein concentrations of the lysates were measured with a DC protein assay reagent (Bio-Rad, CA, USA). Soluble lysates were boiled for 5 min with 2 Â SDS sample buffer. Samples (40 mg per lane) from the total protein fraction were loaded and separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE). Protein was transferred to polyvinylidene difluoride membranes (Pharmacia Corporation, NJ, USA) and probed with primary antibodies against human Arkadia (goat polyclonal antibody, Santa Cruz Biotechnology, Santa Cruz, CA, USA), Smurf2 (goat polyclonal antibody, Santa Cruz Biotechnology), Smad7 (rabbit polyclonal antibody, Santa Cruz Biotechnology), TbRI (rabbit polyclonal antibody, Santa Cruz Biotechnology), E-cadherin (mouse monoclonal antibody, BD Biotechnology, NC, USA), a-SMA (mouse monoclonal antibody, Sigma), and b-actin (mouse monoclonal antibody, Sigma). The primary antibodies that bound to the target proteins were detected using horseradish peroxidase-conjugated anti-rabbit IgG (Promega, Madison, WI, USA), anti-goat IgG (Promega), or anti-mouse IgG (Cortex Biochem, San Leandro, CA, USA), as appropriate. The antibodies were visualized with enhanced chemiluminescent detection (Pierce Biotechnology, Rockford, ZL, USA).
Immunoprecipitation
The cell lysates were preincubated with 2 mg of anti-Smad7 antibody or anti-TbRI antibody and 50 ml of protein G-Sepharose beads at 41C. Immunoprecipitated proteins were washed three times with cold lysis buffer and then separated by SDS-PAGE for immunodetection of associated proteins in the complex. The lysates preincubated with anti-rabbit IgG instead of anti-Smad7 antibody or anti-TbRI antibody were used as negative controls.
Real-time RT-PCR Total RNA was extracted using Trizol (Invitrogen). Reverse transcription of the RNA was performed using a first-strand cDNA synthesis kit (Promega). The PCR with SYBR Green PCR Master Mix (Takara, Shiga, Japan) was used to analyze Arkadia mRNA and Smad7 mRNA. Real-time PCR analysis was performed using the ABI PRISM 7900-HT Sequence Detection System (Applied Biosystems, Foster City, CA, USA). The primer sequences used were as follows: 
Statistical analysis
Data are presented as means ± s.d. Statistical analysis was performed by ANOVA, and significance was defined as Po0.05.
